本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验、/div>
| CAS NO: |
380315-80-0 |
| 规格: |
?8% |
包装与价格：
| 包装 |
价格(? |
| 5mg |
电议 |
| 10mg |
电议 |
| 25mg |
电议 |
| 50mg |
电议 |
| 100mg |
电议 |
| 250mg |
电议 |
| 500mg |
电议 |
| 1g |
电议 |
产品介绍
理化性质和储存条仵/div>
| Molecular Weight (MW) |
369.48 |
| Formula |
C20H23N3O2S |
| CAS No. |
380315-80-0 |
| Storage |
-20 for 3 years in powder form |
| -80 for 2 years in solvent |
| Solubility(In vitro) |
DMSO: 74 mg/mL (200.28 mM) |
| Water:<1 mg/mL (slightly soluble or insoluble) |
| Ethanol:<1 mg/mL |
| Solubility(In vivo) |
15% Captisol: 15 mg/mL |
| Synonyms |
Tenovin-1; Tenovin1; Tenovin 1 |
实验参考方泔/div>
| General |
Initial in vivo experiments indicated that tenovin-1 impairs the growth of BL2-derived tumor xenografts. |
| Animal model |
Female SCID mice injected subcutaneously with ARN8 cells suspended in matrigel. |
| Formulation |
Formulated in 70% cyclodextrin |
| Dosages |
92.5 mg/kg |
| Administration |
i.p. |
| References |
[1] Lain S, et al. Cancer Cell, 2008, 13(5), 454-463. |
m.cnreagent.com
